JCO:儿童癌症幸存者的不良结局存在种族差异吗?

2016-03-29 MedSci MedSci原创

 在过去的四十年中,对于儿童癌症的治疗已经取得的长足的进展,数据显示儿童癌症患者的五年生存率已经达到了85%。伴随着儿童癌症幸存者数量的增加,有必要考虑癌症及其相应的治疗对于儿童的长期影响。早前的研究表明儿童癌症幸存者承受着巨大的发病率和过早死亡的压力。但是鲜有研究关注这一压力在不同种族的儿童癌症幸存者中的差异。 来自加拿大的华人科学家Qi Liu以第一作者身份发表在《临床肿瘤

在过去的四十年中,对于儿童癌症的治疗已经取得的长足的进展,数据显示儿童癌症患者的五年生存率已经达到了85%。伴随着儿童癌症幸存者数量的增加,有必要考虑癌症及其相应的治疗对于儿童的长期影响。早前的研究表明儿童癌症幸存者承受着巨大的发病率和过早死亡的压力。但是鲜有研究关注这一压力在不同种族的儿童癌症幸存者中的差异。

来自加拿大的华人科学家Qi Liu以第一作者身份发表在《临床肿瘤学杂志》上的一篇论文揭示了儿童癌症幸存者不良结局的种族差异。数据来自于儿童癌症幸存者研究。幸存者均是在癌症后生存超过五年。研究人员比较了西班牙裔(750人,5.4%)和非西班牙裔黑人(NHB,694人,5.0%)以及非西班牙裔白人(NHW,12397人,89.6%)患者的后期死亡率、随后的肿瘤发病情况以及慢性疾病。NHB和西班牙裔社会经济地位更低且肥胖的流行率更高,NHB有更高的高血压流行性。NHB有更高的全因死亡率的比例。在接受放疗的NHB中,未发现非黑色素瘤皮肤癌,西班牙裔的幸存者的风险也更低于NHW。NHB和西班牙裔患糖尿病的风险更高。治疗暴露并没有影响死亡率(全因或者具体的原因)、慢性疾病或者随后发生的肿瘤的种族差异性。

通过大规模的数据研究发现,NHB和西班牙裔儿童癌症幸存者有着更大死亡率和发病率的负担。少数的风险差异可以通过社会经济状况的差异或者心血管风险因素的种族差异进行解释。

原始出处:
Qi Liu et al. Racial/Ethnic Differences in Adverse Outcomes Among Childhood Cancer Survivors: The Childhood Cancer Survivor Study. JCO. Published Ahead of Print on March 21, 2016 as 10.1200/JCO.2015.66.3567

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
    2017-03-14 lidong40
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1952350, encodeId=3868195235077, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Jun 12 19:17:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891264, encodeId=819f1891264cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Mar 14 13:17:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353551, encodeId=93e6135355174, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438765, encodeId=aa7f1438e65f3, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511103, encodeId=90ae1511103b4, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Wed Mar 30 15:17:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74564, encodeId=bd67e456472, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Wed Mar 30 07:23:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
    2016-03-30 Gsurgeon

    不错学习了

    0

相关资讯

JAMA:生命早期的抗生素暴露不会增加儿童期的肥胖风险

在动物模型中的结果显示生命早期的抗生素暴露可增加肥胖的风险,这是通过肠道微生物介导的。婴儿抗生素暴露较为常见,且经常使用不恰当。婴儿使用抗生素和儿童体重增加之间的关系的研究报告结果不一致。原始出处:Jeffrey S. Gerber,Matthew Bryan,Rachael K. Ross,et al.Antibiotic Exposure During the First 6 Months o

BMJ Open:你清楚儿童饮品中的糖含量究竟有多高吗?

研究者对英国主要的7家超市进行了一项研究,探究果汁、果汁饮料和冰沙(FJJDS)中糖的含量。只特别向儿童销售的饮品,没有将运动饮料、冰红茶、碳酸饮料等并不是针对儿童的饮品纳入研究。研究者共对203中超市里专门向儿童销售的果汁(n=21)、果汁饮料(n=158)和冰沙(n=24)进行了研究。数据显示,饮品中的糖含量从0-16g/100 ml不等,虽然平均糖含量只有7.0 g/100 ml,但是几乎所

J Pediatr Orthop:ADHA药物会降低骨密度?

近期发表在J Pediatr Orthop的研究表明,服用与注意缺陷多动障碍症(ADHD)相关处方药物的儿童和青少年,其总股骨、股骨颈和腰椎的骨密度(BMD)降低。该研究纳入了5135名8-17岁的参与者,根据自我报告或监护人的报告处获取参与者处方药物的服用情况,根据药物使用情况将其分为药物使用足和非药物使用者,其中药物使用者包括ADHD相关药物和其他药物。此外,通过双能X线扫描获取参与者BMD情

新父母们往这看:NEJM研究表明孩子一岁前吃花生糊可长期预防花生过敏

现在越来越多的人对花生过敏,而一项新研究表明在孩子小的时候让其接触花生能够为孩子提供长久的保护,避免对花生产生过敏。 研究人员与一些存在过敏高风险的宝宝共同进行了这项研究,开始研究的时候这些宝宝已经存在湿疹或对鸡蛋过敏的情况。研究人员在宝宝11个月前定期地喂他们吃一些花生糊,结果发现这样可以降低宝宝对花生过敏的风险,到他们五岁的时候风险降低了80%。 研究人员又对这些孩子进行一年的观察,

Pediatrics:水痘疫苗选择双剂量还是单剂量?

近期发表在Pediatrics的研究称,双剂量水痘疫苗比单剂量更有效。Dana Perella博士和同事对2009-2011年两个监测点诊断为水痘的125名儿童和408名对照组参与者进行了一项病例对照研究,探究双倍剂量水痘疫苗的总体和增量有效性。研究者对接种单剂量水痘疫苗(0-18岁)、双剂量水痘疫苗(4-18岁)的儿童和未接种疫苗的儿童进行了比较。研究数据显示,单剂量水痘疫苗预防水痘的有效性为7

世界肾脏病日:肾脏健康,从儿童预防开始!

今天是第11个世界肾脏病日,今年的主题是:肾脏健康,从儿童预防开始!肾脏病影响世界数百万人的健康,包括许多儿童。因此,对于儿童来说,早期检测和保持健康生活方式非常重要,早期预防,治疗儿童先天性和后天性肾脏病。 近几年来,慢性肾脏病发病出现年轻化趋势,不少尿毒症患者岁数仅仅有二三十岁,最小的只有十几岁。每年青少年肾病患者以13%的速度快速增加,据统计,全国已有超300万青少